Abstract
The purpose of this study was to evaluate the safety and efficacy of debris-capture for distal protection using the FilterWire EZ Embolic Protection System (Boston Scientific, Mountain View, CA) with the additional aim to further define the incidence of distal embolization during superficial femoral artery (SFA) interventions. A prospective, single-centre registry was designed to evaluate the performance of the FilterWire EZ in capturing debris during standard SFA percutaneous intervention. The PRO-RATA study included 30 patients suitable for PTA (Fontaine IIb to III or Rutherford I to II classification). The primary end points were occurrence of distal embolization or decreased runoff, improvement in ankle–brachial index ankle–brachial index (ABI) after the procedure, and number of filters containing emboli. Secondary end points included major adverse events (i.e., procedure- or device-related death and/or clinical target lesion revascularisation), device delivery, deployment success, and incidence of embolic recovery (patients with device success exhibiting embolic protection in the filter). Procedural success was determined as ≤30% residual stenosis with no worsening of distal runoff as determined on angiography. A total of 29 patients (age 66.2 ± 12 years; total no. of limbs = 30; total no. of lesions = 30) suitable for PTA were enrolled in the study between February 2007 and March 2008. There were 26 patients with claudication (Fontaine IIB) and 3 patients with stage IV peripheral vascular disease. In one patient, lesions in both legs were treated. No procedural or device-related complications occured. The average degree of stenosis was 86 ± 7%. Stenosis length ranged from 8 to 88 mm. The average degree of residual stenosis was 10 ± 10%. ABI improved from 0.56 ± 0.16 to 0.92 ± 0.19 (P < 0.05). No restenosis or dissection was seen at 1-month ultrasound follow-up. Macroscopic debris was found in 27 of 30 filters of all distal protection devices used in all 29 patients. Debris particle size ranged from 90 to 2000 μm (1200 ± 640). Histological debris analysis showed platelets, erythrocytes, inflammatory cells, extracellular matrix, and cholesterol as being the major components of emboli. Additional immunochemistry showed no correlation between lesion morphology and debris components. The FilterWire EZ is easy and safe to handle. The system caused no complications. In all cases, macroscopic debris was captured. Using a distal protection device during femoropopliteal interventions has the potential to prevent migration of debris, which may be important for high-risk patients with limited distal runoff.
References
Casserly IP, Abou-Chebl A, Fathi RB et al (2005) Slow-flow phenomenon during carotid artery intervention with embolic protection devices: predictors and clinical outcome. J Am Coll Cardiol 46:1466–1472
Edwards MS, Corriere MA, Craven TE et al (2007) Atheroembolism during percutaneous renal artery revascularization. J Vasc Surg 46:55–61
van Gaal WJ, Choudhury RP, Porto I et al (2007) Prediction of distal embolization during percutaneous coronary intervention in saphenous vein grafts. Am J Cardiol 99:603–606
Kasirajan K, Haskal ZJ, Ouriel K (2001) The use of mechanical thrombectomy devices in the management of acute peripheral arterial occlusive disease. J Vasc Interv Radiol 12:405–411
Wholey MH, Maynar MA, Wholey MH et al (1998) Comparison of thrombolytic therapy of lower-extremity acute, subacute, and chronic arterial occlusions. Catheter Cardiovasc Diagn 44:159–169
Siablis D, Karnabatidis D, Katsanos K et al (2005) Outflow protection filters during percutaneous recanalization of lower extremities’ arterial occlusions: a pilot study. Eur J Radiol 55:243–249
Suri R, Wholey MH, Postoak D et al (2006) Distal embolic protection during femoropopliteal atherectomy. Catheter Cardiovasc Interv 67:417–422
Karnabatidis D, Katsanos K, Kagadis GC et al (2006) Distal embolism during percutaneous revascularization of infra-aortic arterial occlusive disease: an underestimated phenomenon. J Endovasc Ther 13:269–280
Shammas NW, Dippel EJ, Coiner D, et al. (2007) Embolic filter protection in preventing lower extremity distal embolization: preliminary data from the PROTECT registry. Abstract presented at New Cardiovascular Horizons, New Orleans, LA, 5–7 September 2007
Lin PH, Bush RL, Conklin BS et al (2002) Late complication of aortoiliac stent placement—atheroembolization of the lower extremities. J Surg Res 103:153–159
Dyett JF, Shaw JW, Cook AM et al (1993) The use of the Wallstent in aorto-iliac vascular disease. Clin Radiol 48:227–231
Uher P, Nyman U, Lindh M et al (2002) Long-term results of stenting for chronic iliac artery occlusion. J Endovasc Ther 9:67–75
Matchett WJ, McFarland DR, Eidt JF et al (2000) Blue toe syndrome: treatment with intra-arterial stents and review of therapies. J Vasc Interv Radiol 11:585–592
Molloy KJ, Nasim A, London NJ, Naylor AR, Bell PR, Fishwick G, Bolia A, Thompson MM (2003) Percutaneous transluminal angioplasty in the treatment of critical limb ischemia. J Endovasc Ther 10:298–303
Jahnke T, Schäfer JP, Bolte H, Schäfer F, Michalek J, Charalambous N, Sapoval M, Müller-Hülsbeck S (2008) Retrospective study of rapid-exchange monorail versus over-the-wire technique for femoropopliteal angioplasty. Cardiovasc Interv Radiol 31:854–859
Nydahl S, Hartshorne T, Bell PR, Bolia A, London NJ (1997) Subintimal angioplasty of infrapopliteal occlusions in critically ischaemic limbs. Eur J Vasc Endovasc Surg 14:212–216
Matsi PJ, Manninen HI (1998) Complications of lower-limb percutaneous transluminal angioplasty: a prospective analysis of 410 procedures on 295 consecutive patients. Cardiovasc Interv Radiol 21:361–366
Rickard MJ, Fisher CM, Soong CV et al (1997) Limitations of intra-arterial thrombolysis. Cardiovasc Surg 5:634–640
Chalmers RTA, Hoballah JJ, Kresowik TF et al (1995) Late results of a prospective study of direct intra-arterial urokinase infusion for peripheral arterial and bypass graft occlusions. Cardiovasc Surg 3:293–297
Wholey MH, Maynar MA, Wholey MH et al (1998) Comparison of thrombolytic therapy of lower-extremity acute, subacute, and chronic arterial occlusions. Catheter Cardiovasc Diagn 44:159–169
Kasirajan K, Gray B, Beavers FP et al (2001) Rheolytic thrombectomy in the management of acute and subacute limb-threatening ischemia. J Vasc Interv Radiol 12:413–421
Reekers JA, Kromhout JG, Spithoven HG et al (1996) Arterial thrombosis below the inguinal ligament: percutaneous treatment with a thrombosuction catheter. Radiology 198:49–53
Wholey M, Toursarkissian B, Postoak D et al (2005) Early experience in the application of distal protection devices in treatment of peripheral vascular disease of the lower extremities. Catheter Cardiovasc Interv 64:227–235
König CW, Pusich B, Tepe G, Wendel HP, Hahn U, Schneider W, Claussen CD, Duda SH (2003) Frequent embolization in peripheral angioplasty: Detection with an embolism protection device (AngioGuard) and electron microscopy. Cardiovasc Interv Radiol 26:334–339
Shammas NW, Dippel EJ, Coiner D, Shammas GA, Jerin M, Kumar A (2008) Preventing lower extremity distal embolization using embolic filter protection: results of the PROTECT registry. J Endovasc Ther 15:270–276
Müller-Hülsbeck S, Stolzmann P, Liess C, Hedderich J, Paulsen F, Jahnke T, Heller M (2005) Vessel wall damage caused by cerebral protection devices: ex vivo evaluation in porcine carotid arteries. Radiology 235:454–460
Allie DE (2008) To protect or not to protect? In lower extremity angioplasty procedures, “Why not” is the question!. J Endovasc Ther 15:277–282
Lam RC, Shah S, Faries PL et al (2007) Incidence and clinical significance of distal embolization during percutaneous intervention involving the superficial femoral artery. J Vasc Surg 46:1155–1159
Conflict of interest
Protection devices were provided free of charge for this evaluation and sponsored by Boston Scientific Corporation. S. M.-H. has consultancy relations with Terumo, Boston Scientific, and EV3 and has had travel and accommodations expenses covered or reimbursed by Abbott Vascular, Terumo, Boston, Ev3, Invatec, Cordis, and Medtronic, as regulated in dedicated contracts. The other authors have declared that no potential conflicts of interest exist.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Müller-Hülsbeck, S., Hümme, T.H., Philipp Schäfer, J. et al. Final Results of the Protected Superficial Femoral Artery Trial Using the FilterWire EZ System. Cardiovasc Intervent Radiol 33, 1120–1127 (2010). https://doi.org/10.1007/s00270-010-9936-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00270-010-9936-5